PIM3 and familial pancreatic carcinoma: PIM3 has been shown to promote growth and angiogenesis of human pancreatic cancer cells in vivo in an orthotopic nude mouse model [14], and the inhibition of PIM3 kinase halts the growth of human tumors that were injected into nude mice, suggesting that PIM3 is a potential molecular target for cancer therapy [6].